[go: up one dir, main page]

TW200621306A - Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds - Google Patents

Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds

Info

Publication number
TW200621306A
TW200621306A TW094136993A TW94136993A TW200621306A TW 200621306 A TW200621306 A TW 200621306A TW 094136993 A TW094136993 A TW 094136993A TW 94136993 A TW94136993 A TW 94136993A TW 200621306 A TW200621306 A TW 200621306A
Authority
TW
Taiwan
Prior art keywords
methyl
glucamine
compounds
dermal delivery
compositions
Prior art date
Application number
TW094136993A
Other languages
English (en)
Inventor
Annette Tobia
Francis Kappler
Original Assignee
Dynamis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynamis Therapeutics Inc filed Critical Dynamis Therapeutics Inc
Publication of TW200621306A publication Critical patent/TW200621306A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094136993A 2004-10-22 2005-10-21 Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds TW200621306A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62137104P 2004-10-22 2004-10-22

Publications (1)

Publication Number Publication Date
TW200621306A true TW200621306A (en) 2006-07-01

Family

ID=36228326

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094136993A TW200621306A (en) 2004-10-22 2005-10-21 Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds

Country Status (4)

Country Link
US (1) US20060110439A1 (zh)
EP (1) EP1802278A4 (zh)
TW (1) TW200621306A (zh)
WO (1) WO2006047409A2 (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060216264A1 (en) * 2005-03-24 2006-09-28 Maguire Amalia D Eurpoean slenderizing seaweed bath
US20070148222A1 (en) * 2005-12-28 2007-06-28 Discovery Partners Llc Skin treatment compositions containing copper-pigment complexes
US20070148224A1 (en) * 2005-12-28 2007-06-28 Discovery Partners Llc Skin treatment compositions containing copper-pigment complexes
US20100297046A1 (en) * 2006-03-31 2010-11-25 Dynamis Therapeutics, Inc. Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors
WO2008045272A2 (en) * 2006-10-06 2008-04-17 Dynamis Therapeutics, Inc. Compositions and methods for skin lightening
US7850382B2 (en) 2007-01-18 2010-12-14 Sanford, L.P. Valve made from two materials and writing utensil with retractable tip incorporating same
US7488130B2 (en) 2007-02-01 2009-02-10 Sanford, L.P. Seal assembly for retractable instrument
US20120141576A1 (en) * 2007-03-15 2012-06-07 Benjamin Johnson Treatment of Dermatologic Skin Disorders
US20090035398A1 (en) * 2007-03-29 2009-02-05 Raymond Williams Topical formulations
CA2697044A1 (en) * 2007-08-21 2009-02-26 Alza Corporation Liposome formulations of boronic acid compounds
US8226312B2 (en) 2008-03-28 2012-07-24 Sanford, L.P. Valve door having a force directing component and retractable instruments comprising same
US8221012B2 (en) 2008-11-07 2012-07-17 Sanford, L.P. Retractable instruments comprising a one-piece valve door actuating assembly
US8393814B2 (en) 2009-01-30 2013-03-12 Sanford, L.P. Retractable instrument having a two stage protraction/retraction sequence
US8647661B1 (en) 2010-11-05 2014-02-11 Florida A&M University Surface modified multilayered nanostructures for dermal delivery
CN107184569A (zh) 2012-08-09 2017-09-22 迪纳米斯治疗公司 保持或改善对象健康、幸福和/或生理功能的方法
US9023826B2 (en) 2012-10-12 2015-05-05 L'oreal S.A. Compositions containing adenosine and the hydrotropes caffeine and nicotinamide for cosmetic use
JP6295261B2 (ja) 2012-10-12 2018-03-14 ロレアル 少なくとも一種のヒドロトロープ及び少なくとも一種の活性化合物を含む化粧品組成物
US9072919B2 (en) 2012-10-12 2015-07-07 L'oreal S.A. Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid
US9107853B2 (en) 2012-10-12 2015-08-18 L'oreal S.A. Compositions containing phenolic compounds and hydrotropes for cosmetic use
US9018177B2 (en) 2012-10-12 2015-04-28 L'oreal S.A. Cosmetic compositions for increasing bioavailability of the active compounds baicalin and/or vitamin C
WO2014144365A1 (en) * 2013-03-15 2014-09-18 University Of Maryland, College Park Nano-liposomal formulations and methods of use
US9669242B2 (en) 2013-07-01 2017-06-06 L'oreal Compositions containing at least two phenolic compounds, a lipid-soluble antioxidant and at least one hydrotrope for cosmetic use
JP2019500109A (ja) * 2015-12-15 2019-01-10 ロレアル ビタミンｃを送達するための、イオン泳動法、イオン泳動組成物、キットおよびイオン泳動デバイス
EP3181117A1 (en) * 2015-12-15 2017-06-21 L'oreal Vitamin c composition and an iontophoresis method for its delivery
JP6873598B2 (ja) * 2015-12-22 2021-05-19 ロレアル 活性成分のための改善された局所送達系
EP3972557A1 (en) * 2019-05-22 2022-03-30 3M Innovative Properties Company Oral compositions and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) * 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4195172A (en) * 1976-04-22 1980-03-25 Politechnika Gdanska Salts of N-glycosyl derivatives of polyene macrolides, especially N-methylglucamine salts as well as the method of their preparation
US4186183A (en) * 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
CH672733A5 (zh) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
US6576636B2 (en) * 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US6696069B2 (en) * 2000-06-30 2004-02-24 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof
WO2002078667A1 (en) * 2001-03-29 2002-10-10 The Dial Corporation Antibacterial compositions for skin care
US7622117B2 (en) * 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
KR101045658B1 (ko) * 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물

Also Published As

Publication number Publication date
US20060110439A1 (en) 2006-05-25
WO2006047409A3 (en) 2006-09-08
EP1802278A2 (en) 2007-07-04
WO2006047409A2 (en) 2006-05-04
EP1802278A4 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
TW200621306A (en) Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
TW200618817A (en) Diffractive colorants for cosmetics
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
WO2009129246A3 (en) Compositions and methods for preparing and using same
TW200800975A (en) New compounds 2
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
SG155912A1 (en) B-cell reduction using cd37-specific and cd20-specific binding molecules
SI1871416T1 (sl) Metode za zdravljenje boleäśine zaradi osteoartritisa z administracijo zaviralca ĺ˝iväśnega rastnega dejavnika in zmesi, ki ga vsebujejo
WO2007082068A3 (en) Methods and compositions for treating asthma in human and non human primates
WO2010014595A3 (en) Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2005092009A3 (en) Acetylcholinesterase inhibitors and n-methyl-d-aspartate antagonists useful in the treatment of cognitive disorders
WO2009156680A3 (fr) Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition pharmaceutique la contenant et son utilisation dans le traitement des troubles cognitifs
WO2006034491A3 (en) Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
TW200700071A (en) Novel use
WO2004098599A3 (en) Proton pump inhibitors for the treatment of lower abdominal disorders
WO2008036733A3 (en) Methods for treatment of vesicle transport disorders
TW200726763A (en) Novel compound
WO2006012536A3 (en) Methods and compositions for treating lactose intolerance
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes